Skip to main navigation Skip to search Skip to main content

A Multicenter, Randomized, Double-blind, Active-Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients with Treatment Resistant Major Depression

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date09/19/11 → 09/18/12

Funding

  • Bristol Myers Squibb Company: $10,000.00